[House Report 106-975]
[From the U.S. Government Publishing Office]



106th Congress                                                   Report
                        HOUSE OF REPRESENTATIVES
 2d Session                                                     106-975

======================================================================



 
PROVIDING FOR CONSIDERATION OF A MOTION TO CONCUR IN THE SENATE 
  AMENDMENT WITH AN AMENDMENT TO H.R. 4386, THE BREAST AND CERVICAL 
  CANCER PREVENTION AND TREATMENT ACT OF 2000

                                _______
                                

  October 11, 2000.--Referred to the House Calendar and ordered to be 
                                printed

                                _______
                                

   Mrs. Myrick, from the Committee on Rules, submitted the following

                              R E P O R T

                       [To accompany H. Res. 628]

    The Committee on Rules, having had under consideration 
House Resolution 628, by a nonrecord vote, report the same to 
the House with the recommendation that the resolution be 
adopted.

                  summary of provisions of resolution

    The resolution provides for consideration in the House of a 
motion to concur in the Senate amendment to H.R. 4386, the 
Breast and Cervical Cancer Prevention and Treatment Act of 
2000, with an amendment. The rule waives all points of order 
against the motion. The rule provides one hour of debate on the 
motion equally divided and controlled by the chairman and 
ranking minority member of the Committee on Commerce. Finally, 
the rule waives all points of order against the amendment 
printed in this report.
    Text of amendment made in order under the rule:
  Add at the end of the Senate amendment the following section:

SEC. 3. HUMAN PAPILLOMAVIRUS; ACTIVITIES OF CENTERS FOR DISEASE CONTROL 
                    AND PREVENTION.

  Part B of title III of the Public Health Service Act (42 
U.S.C. 243 et seq.) is amended by inserting before section 318 
the following section:

                         ``human papillomavirus

  ``Sec. 317P. (a) Surveillance.--
          ``(1) In general.--The Secretary, acting through the 
        Director of the Centers for Disease Control and 
        Prevention, shall--
                  ``(A) enter into cooperative agreements with 
                States and other entities to conduct sentinel 
                surveillance or other special studies that 
                would determine the prevalence in various age 
                groups and populations of specific types of 
                human papillomavirus (referred to in this 
                section as `HPV') in different sites in various 
                regions of the United States, through 
                collection of special specimens for HPV using a 
                variety of laboratory-based testing and 
                diagnostic tools; and
                  ``(B) develop and analyze data from the HPV 
                sentinel surveillance system described in 
                subparagraph (A).
          ``(2) Report.--The Secretary shall make a progress 
        report to the Congress with respect to paragraph (1) 
        not later than one year after the effective date of 
        this section.
  ``(b) Prevention Activities; Education Program.--
          ``(1) In general.--The Secretary, acting through the 
        Director of the Centers for Disease Control and 
        Prevention, shall conduct prevention research on HPV, 
        including--
                  ``(A) behavioral and other research on the 
                impact of HPV-related diagnoses on individuals;
                  ``(B) formative research to assist with the 
                development of educational messages and 
                information for the public, for patients, and 
                for their partners about HPV;
                  ``(C) surveys of physician and public 
                knowledge, attitudes, and practices about 
                genital HPV infection; and
                  ``(D) upon the completion of and based on the 
                findings under subparagraphs (A) through (C), 
                develop and disseminate educational materials 
                for the public and health care providers 
                regarding HPV and its impact and prevention.
          ``(2) Report; final proposal.--The Secretary shall 
        make a progress report to the Congress with respect to 
        paragraph (1) not later than one year after the 
        effective date of this section, and shall develop a 
        final proposal not later than two years after such 
        effective date, including a detailed summary of the 
        significant findings and problems and the best 
        strategies to prevent future infections.
  ``(c) HPV Education and Prevention.--
          ``(1) In general.--The Secretary shall prepare and 
        distribute educational materials for health care 
        providers and the public that include information on 
        all sexually transmitted diseases, including HPV and 
        HIV infection. Such materials shall address--
                  ``(A) modes of transmission;
                  ``(B) consequences of infection, including 
                the link between HPV and cervical cancer;
                  ``(C) the effectiveness or lack of 
                effectiveness of both condoms and abstinence in 
                preventing infection with sexually transmitted 
                diseases, including HPV; and
                  ``(D) the importance of regular pap smears, 
                HIV testing, and sexually-transmitted-disease 
                screening for early intervention purposes.
          ``(2) Medically accurate information.--Educational 
        materials under paragraph (1), and all other relevant 
        educational and prevention materials prepared for the 
        public and health care providers by the Secretary 
        (including materials prepared through the Food and Drug 
        Administration, the Centers for Disease Control and 
        Prevention, and the Health Resources and Services 
        Administration), or by other Federal departments or 
        agencies, or by contractors, grantees, or subgrantees 
        thereof, that are specifically designed to address 
        sexually transmitted diseases or condoms shall contain 
        medically accurate information regarding the 
        effectiveness or lack of effectiveness of condoms in 
        preventing HPV infection, HIV infection, and other 
        sexually transmitted diseases. Such requirement only 
        applies to materials mass produced for the public and 
        health care providers, and not to routine 
        communications.''.

SEC. 4. LABELING OF CONDOMS WITH RESPECT TO HUMAN PAPILLOMAVIRUS AND 
                    OTHER SEXUALLY TRANSMITTED DISEASES.

   The Secretary of Health and Human Services shall reexamine 
existing condom labels that are authorized pursuant to the 
Federal Food, Drug, and Cosmetic Act to ensure that the labels 
are medically accurate and not misleading regarding the overall 
effectiveness and lack of effectiveness of condoms in 
preventing sexually transmitted diseases, including HIV 
infection and infection with the human papillomavirus.

                                  
